Leading Edge Financial Planning LLC Merck & Co., Inc. Transaction History

Leading Edge Financial Planning LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $2,367 - $2,629	-23 Reduced 1.01%	2,259 $233 Million
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $27,261 - $29,713	251 Added 12.36%	2,282 $263 Million
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $823 - $918	8 Added 0.4%	2,031 $216 Million
Q4 2022 Mar 02, 2023	BUY	$87.44 - $112.11 $176,891 - $226,798	2,023 New	2,023 $224 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Leading Edge Financial Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Leading Edge Financial Planning LLC with notifications on news.